New patent is a major advancement in the
capabilities of speech analysis and has the potential to
revolutionize various industries including healthcare and customer
service
PROVO,
Utah, Sept. 10, 2024 /PRNewswire/ -- Canary
Speech Inc., the leading AI-powered voice biomarker technology
company, is proud to announce the award of a new patent for its
innovative paired neural networks system, officially titled "Paired
Neural Networks for Speech Analysis" (US Patent No.
US20230072242A1). This patent is a major advancement in the
capabilities of speech analysis and has the potential to
revolutionize various industries including healthcare and customer
service.
"This technology has the potential to
change how we understand and interact with speech..."
The newly granted patent, US20230072242A1, details a
sophisticated system employing paired neural networks to analyze
and interpret speech with unprecedented accuracy. This technology
uses advanced artificial intelligence to process vocal inputs,
providing insights into a speaker's health, emotional state, and
other critical metrics.
"We are thrilled to receive this patent, which represents years
of hard work and innovation by our talented team," said
Henry O'Connell, CEO of Canary
Speech. "This technology has the potential to change how we
understand and interact with speech, opening up new possibilities
across various industries."
Paired neural network technology identifies subtle shifts in an
individual's voice by analyzing it against previous samples from
the same person. This breakthrough enables the delivery of highly
personalized vocal biomarkers, enhancing accuracy by filtering out
individual vocal traits and focusing on changes that may indicate
the presence of various diseases and other health conditions.
Canary Speech's patent portfolio now has 14 patents (8
issued and 6 pending), leading all competitors in the industry for
awarded patents. Based on its unique approach, Canary Speech uses
vocal biomarkers that capture a data set of over 15 million data
elements every minute of conversational speech to establish an
extensive set of patents. These patents include three families of
distinct claims. Canary Speech has full ownership of these patents.
No prior art was identified for each of the issued patents, and all
claims were awarded. The patent portfolio includes primary and
continuation patents under the following patent titles:
- Medical Assessment Based on Voice
- Selecting Speech Features for Building Models for Detecting
Medical Conditions
- Paired Neural Networks for Diagnosing Health Conditions
"The paired neural networks system is a game-changer in speech
analysis. Where available, using previous voice samples from a
patient creates the ability to focus on an individual's specific
speech patterns and vocal tract in truly personalized medicine. We
are eager to see the impact it will have in healthcare, customer
service, and beyond," said Nate
Blaylock, Chief Technical Officer at Canary Speech.
Canary Speech's achievement in securing this patent is a
testament to its commitment to pushing the boundaries of what is
possible with speech analysis technology. The company's dedication
to research and development has positioned itself as a leader in
the field, continually striving to bring cutting-edge solutions to
market.
To learn more about Canary Speech, visit
Canaryspeech.com.
About Canary Speech
Canary Speech is the leading AI-powered voice biomarker health
tech company that uses real-time patented vocal analysis to screen
for mental health and neurological disorders. Canary's vocal
biomarker technology captures and analyzes speech data within
seconds to identify irregularities in behavioral and cognitive
changes before current clinical screening standards or noticeable
symptoms for invisible illnesses like anxiety, depression and
dementia. Canary Speech is a Utah-based company that advances speech and
language applications for health systems, payers and pharmaceutical
markets.
Press Contact:
Caitlyn Brooksby
caitlyn@canaryspeech.com
Disclaimer: This press release contains
forward-looking statements that are subject to risks and
uncertainties. Actual results may differ materially from those
anticipated due to various factors.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/canary-speech-receives-patent-for-paired-neural-networks-technology-302244065.html
SOURCE Canary Speech